Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takeshi Hirota

Showing results (1-10 of 84) with videos related to

Pageof 9
Sort By:
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|November 2, 2018
[Epigenetic Regulation of Pharmacokinetic-related Genes in Human Tissues]Takeshi Hirota
Expert Opinion on Drug Metabolism & Toxicology|January 22, 2024
Interindividual variability in statin pharmacokinetics and effects of drug transportersTakeshi Hirota, Ichiro Ieiri
Expert Opinion on Drug Metabolism & Toxicology|June 11, 2015
Drug-drug interactions that interfere with statin metabolismTakeshi Hirota, Ichiro Ieiri
Molecular Pharmacology|October 27, 2017
Relationship between DNA Methylation in the 5' CpG Island of the <i>SLC47A1</i> (Multidrug and Toxin Extrusion Protein MATE1) Gene and Interindividual Variability in MATE1 Expression in the Human LiverToshihiro Tanaka, Takeshi Hirota, Ichiro Ieiri
Clinical Pharmacokinetics|June 20, 2018
Clinical Pharmacokinetics of Anaplastic Lymphoma Kinase Inhibitors in Non-Small-Cell Lung CancerTakeshi Hirota, Shota Muraki, Ichiro Ieiri
Drug Metabolism and Pharmacokinetics|November 21, 2012
Impact of genetic polymorphisms in CYP2C9 and CYP2C19 on the pharmacokinetics of clinically used drugsTakeshi Hirota, Shunsuke Eguchi, Ichiro Ieiri
Expert Opinion on Drug Metabolism & Toxicology|July 31, 2020
An updated review of pharmacokinetic drug interactions and pharmacogenetics of statinsTakeshi Hirota, Yuito Fujita, Ichiro Ieiri
Expert Opinion on Drug Safety|June 27, 2025
Adverse event profiles of four monomethyl auristatin E-conjugated antibody drug conjugates: a disproportionality analysis based on the US FDA adverse event reporting system (FAERS) databaseYohei Doi, Ichiro Ieiri, Mayako Uchida, et al.
Clinical Pharmacokinetics|July 5, 2022
Clinical Pharmacokinetics and Pharmacodynamics of Fostamatinib and Its Active Moiety R406Ryosuke Matsukane, Kimitaka Suetsugu, Takeshi Hirota, et al.
Current Drug Metabolism|January 29, 2008
Epigenetic regulation of genes encoding drug-metabolizing enzymes and transporters; DNA methylation and other mechanismsTakeshi Hirota, Hiroshi Takane, Shun Higuchi, et al.
Pageof 9

Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|November 2, 2018
[Epigenetic Regulation of Pharmacokinetic-related Genes in Human Tissues]Takeshi Hirota
Expert Opinion on Drug Metabolism & Toxicology|January 22, 2024
Interindividual variability in statin pharmacokinetics and effects of drug transportersTakeshi Hirota, Ichiro Ieiri
Expert Opinion on Drug Metabolism & Toxicology|June 11, 2015
Drug-drug interactions that interfere with statin metabolismTakeshi Hirota, Ichiro Ieiri
Molecular Pharmacology|October 27, 2017
Relationship between DNA Methylation in the 5' CpG Island of the <i>SLC47A1</i> (Multidrug and Toxin Extrusion Protein MATE1) Gene and Interindividual Variability in MATE1 Expression in the Human LiverToshihiro Tanaka, Takeshi Hirota, Ichiro Ieiri
Clinical Pharmacokinetics|June 20, 2018
Clinical Pharmacokinetics of Anaplastic Lymphoma Kinase Inhibitors in Non-Small-Cell Lung CancerTakeshi Hirota, Shota Muraki, Ichiro Ieiri
Drug Metabolism and Pharmacokinetics|November 21, 2012
Impact of genetic polymorphisms in CYP2C9 and CYP2C19 on the pharmacokinetics of clinically used drugsTakeshi Hirota, Shunsuke Eguchi, Ichiro Ieiri
Expert Opinion on Drug Metabolism & Toxicology|July 31, 2020
An updated review of pharmacokinetic drug interactions and pharmacogenetics of statinsTakeshi Hirota, Yuito Fujita, Ichiro Ieiri
Expert Opinion on Drug Safety|June 27, 2025
Adverse event profiles of four monomethyl auristatin E-conjugated antibody drug conjugates: a disproportionality analysis based on the US FDA adverse event reporting system (FAERS) databaseYohei Doi, Ichiro Ieiri, Mayako Uchida, et al.
Clinical Pharmacokinetics|July 5, 2022
Clinical Pharmacokinetics and Pharmacodynamics of Fostamatinib and Its Active Moiety R406Ryosuke Matsukane, Kimitaka Suetsugu, Takeshi Hirota, et al.
Current Drug Metabolism|January 29, 2008
Epigenetic regulation of genes encoding drug-metabolizing enzymes and transporters; DNA methylation and other mechanismsTakeshi Hirota, Hiroshi Takane, Shun Higuchi, et al.
Pageof 9